SUBSEQUENT ANDROGEN DEPRIVATION THERAPY AFTER INITIAL TREATMENT IN INTERMEDIATE RISK PROSTATE CANCER: PROSPECTIVE DATA FROM A PHASE III TRIAL

被引：0
|
作者：
Nabid, Abdenour [1 ]
Carrier, Nathalie [1 ]
Vigneault, Eric [2 ]
Thu Van Nguyen [3 ]
Vavassis, Peter [3 ]
Brassard, Marc-Andre [1 ]
Bahoric, Boris [3 ]
Archambault, Robert [4 ,5 ]
Vincent, Francois [3 ]
Bettahar, Redouane [2 ]
Wilke, Derek [6 ]
Souhami, Luis [3 ]
Nabid, Abdenour [1 ]
机构：
[1] Univ Sherbrooke, Sherbrooke, PQ, Canada
[2] Univ Laval, Quebec City, PQ, Canada
[3] Univ Montreal, Montreal, PQ, Canada
[4] Univ Quebec Outaouais, Gatineau, PQ, Canada
[5] McGill Univ, Gatineau, PQ, Canada
[6] Dalhousie Univ, Halifax, NS, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 139卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
24
引用
收藏
页码：S13 / S14
页数：2
相关论文
共 50 条
  • [21] A phase II trial of androgen deprivation therapy (ADT) plus chemotherapy as initial treatment for local failures or advanced prostate cancer
    Amato, Robert
    Stepankiw, Mika
    Gonzales, Patricia
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1629 - 1634
  • [22] Sexual outcomes in high risk prostate cancer treated with long term androgen deprivation therapy and radiotherapy: results from a phase III trial
    Nabid, Abdenour
    Carrier, Nathalie
    Martin, Andre-Guy
    Bahary, Jean-Paul
    Souhami, Luis
    Duclos, Marie
    Vincent, Francois
    Vass, Sylvie
    Bahoric, Boris
    Archambault, Robert
    Lemaire, Celine
    QUALITY OF LIFE RESEARCH, 2016, 25 : 36 - 36
  • [23] Quality of Life and Weight Variation during Androgen Deprivation Therapy in Patients with High -Risk Prostate Cancer: Long-Term Data from a Phase III Trial
    Nabid, A.
    Carrier, N.
    Martin, A. G.
    Bahary, J. P.
    Vavassis, P.
    Vass, S. T., Jr.
    Bahoric, B.
    Archambault, R.
    Vincent, F.
    Bettahar, R.
    Duclos, M.
    Souhami, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E566 - E567
  • [24] Impact of testosterone recovery after androgen deprivation therapy on overall survival in patients with high-risk prostate cancer: Long-term data from a phase III trial.
    Nabid, Abdenour
    Carrier, Nathalie
    Martin, Andre-Guy
    Bahary, Jean-Paul
    Vavassis, Peter
    Vass, Sylvie
    Bahoric, Boris
    Archambault, Robert
    Vincent, Francois
    Bettahar, Redouane
    Duclos, Marie
    Souhami, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [25] RISK OF DEMENTIA FOLLOWING ANDROGEN DEPRIVATION THERAPY FOR TREATMENT OF PROSTATE CANCER
    Krasnova, Anna
    Tully, Karl Heinrich
    Epstein, Matthew
    Marchese, Maya
    Dickermann, Barbra A.
    Cole, Alexander Putnam
    Lipsitz, Stuart R.
    Nguyen, Paul L.
    Kibel, Adam S.
    Choueiri, Toni K.
    Basaria, Shehzad Sultan
    Mucci, Lorelei A.
    Sun, Maxine
    Quoc-Dien Trinh
    JOURNAL OF UROLOGY, 2019, 201 (04): : E564 - E564
  • [26] Risk of dementia following androgen deprivation therapy for treatment of prostate cancer
    Anna Krasnova
    Matthew Epstein
    Maya Marchese
    Barbra A. Dickerman
    Alexander P. Cole
    Stuart R. Lipsitz
    Paul L. Nguyen
    Adam S. Kibel
    Toni K. Choueiri
    Shehzad Basaria
    Lorelei A. Mucci
    Maxine Sun
    Quoc-Dien Trinh
    Prostate Cancer and Prostatic Diseases, 2020, 23 : 410 - 418
  • [27] Risk of dementia following androgen deprivation therapy for treatment of prostate cancer
    Krasnova, Anna
    Epstein, Matthew
    Marchese, Maya
    Dickerman, Barbra A.
    Cole, Alexander P.
    Lipsitz, Stuart R.
    Nguyen, Paul L.
    Kibel, Adam S.
    Choueiri, Toni K.
    Basaria, Shehzad
    Mucci, Lorelei A.
    Sun, Maxine
    Trinh, Quoc-Dien
    PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (03) : 410 - 418
  • [28] Rethinking the Balance of Risk and Benefit of Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer
    Nguyen, Paul L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (05): : 975 - 977
  • [29] Androgen Deprivation Therapy and Radiotherapy Practice Patterns for Unfavorable Intermediate Risk Prostate Cancer
    Hasan, Shaakir
    Lazarev, Stanislav
    Garg, Madhur
    Mehta, Keyur
    Press, Robert
    Chhabra, Arpit
    Choi, J. Isabelle
    Simone, Charles
    Gorovets, Daniel
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S63 - S63
  • [30] Hypofractionated radiotherapy and androgen deprivation in intermediate risk prostate cancer
    Bracci, S.
    Osti, M. F.
    Agolli, L.
    Bertaccini, L.
    De Sanctis, V.
    Valeriani, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S641 - S641
12345